Analysis of tumor microenvironment identifies pathways predicting response to checkpoint control inhibitors: A case study comparing the immune microenvironment of uveal melanoma vs skin cutaneous melanoma

被引：0
|
作者：
Gupta, Ravi
Mandloi, Nitin
Patil, Ashwini
Manoharan, Malini
Sathian, Rekha
Paul, Kiran V.
Chaudhuri, Amitabha
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2016年 / 4卷 / 11期
关键词：
D O I：
10.1158/2326-6066.IMM2016-A121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A121
引用
收藏
页数：2
相关论文
共 32 条
  • [21] Zebrafish modeling reveals that SPINT1 regulates the aggressiveness of skin cutaneous melanoma and its crosstalk with tumor immune microenvironment
    Elena Gómez-Abenza
    Sofía Ibáñez-Molero
    Diana García-Moreno
    Inmaculada Fuentes
    Leonard I. Zon
    Maria C. Mione
    María L. Cayuela
    Chiara Gabellini
    Victoriano Mulero
    Journal of Experimental & Clinical Cancer Research, 38
  • [22] Liquid biopsy reflecting a T-cell permissive tumor microenvironment identifies metastatic melanoma patients responding to immune checkpoint inhibitor therapy
    Jensen, Christina
    Sinkeviciute, Dovile
    Madsen, Daniel H.
    Onnerfjord, Patrik
    Hansen, Morten
    Schmidt, Henrik
    Svane, Inge Marie
    Karsdal, Morten A.
    Willumsen, Nicholas
    CANCER RESEARCH, 2020, 80 (16)
  • [23] MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients: A retrospective study.
    Saint-Ghislain, Mathilde
    Geoffrois, Lionnel
    Gastaud, Lauris
    Lesimple, Thierry
    Negrier, Sylvie
    Penel, Nicolas
    Kurtz, Jean Emmanuel
    Le Corre, Yannick
    Dutriaux, Caroline
    Gardrat, Sophie
    Barnhill, Raymond
    Matet, Alexandre
    Cassoux, Nathalie
    Ramtohul, Toulsie
    Servois, Vincent
    Mariani, Pascale
    Piperno-Neumann, Sophie
    Rodrigues, Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Commentary: Breaking down non-small cell lung cancer tumor microenvironment heterogeneity and predicting response to immune checkpoint inhibitors
    Boys, Joshua
    Onaitis, Mark
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 159 (04): : 1612 - 1613
  • [25] Uveal melanoma: Real-world analysis of immune checkpoint inhibitors efficacy and lymphocyte-to-monocyte ratio as a biomarker of response.
    Desilets, Antoine
    Beland, Chloe
    Hladky, Valerie
    Pang, Steph A.
    Elkrief, Arielle
    Stepanov, Andreea
    Routy, Bertrand
    Belanger, Karl
    Miller, Wilson H.
    Larochelle, Olivier
    Jamal, Rahima
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [26] Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response
    Li, Shanshan
    Zhao, Junjie
    Wang, Guangyu
    Yao, Qingping
    Leng, Zhe
    Liu, Qinglei
    Jiang, Jun
    Wang, Wei
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (06)
  • [27] Adjuvant Therapy with Immune Checkpoint Inhibitors after Carbon Ion Radiotherapy for Mucosal Melanoma of the Head and Neck: A Case-Control Study
    Mizoguchi, Nobutaka
    Kano, Kio
    Okuda, Tatsuya
    Koge, Hiroaki
    Shima, Satoshi
    Tsuchida, Keisuke
    Takakusagi, Yosuke
    Kawashiro, Shohei
    Yoshida, Manatsu
    Kitani, Yuka
    Hashimoto, Kaori
    Furukawa, Madoka
    Shirai, Katsuyuki
    Kamada, Tadashi
    Yoshida, Daisaku
    Katoh, Hiroyuki
    CANCERS, 2024, 16 (15)
  • [28] Intratumoral coxsackievirus A21 increases immune-cell infiltrates and upregulates immune-checkpoint molecules in the tumor microenvironment of advanced melanoma patients: phase II CALM extension study
    Andtbacka, Robert
    Curti, Brendan
    Hallmeyer, Sigrun
    Peng, Zipei
    Paustian, Christopher
    Bifulco, Carlo
    Fox, Bernard
    Grose, Mark
    Shafren, Darren R.
    CANCER RESEARCH, 2016, 76
  • [29] High expression of ferroptosis-sensitizer ACSL4 as an indicator of good response to immune checkpoint inhibitors and preferable survival with increased TIICs in skin cutaneous melanoma.
    Wu, Jinchun
    He, Zhengxi
    Liu, Xianyu
    Mou, Yanhua
    Lu, Jingchen
    Duan, Chaojun
    Li, Bin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] AN EXPLORATORY COST-EFFECTIVENESS ANALYSIS OF CANCER VACCINES IN COMBINATION WITH CURRENT IMMUNE CHECKPOINT INHIBITORS VS IMMUNE CHECKPOINT INHIBITOR MONOTHERAPY: A CASE STUDY FOR V940 IN HIGH-RISK STAGE 3 MELANOMA IN THE US
    Mclean, A.
    van Hest, N.
    VALUE IN HEALTH, 2024, 27 (12) : S124 - S124
1234